Moloney Securities Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$461K Sell
722
-209
-22% -$127K 0.05% 285
2025
Q2
$499K Sell
931
-214
-19% -$102K 0.06% 264
2025
Q1
$481K Buy
1,145
+241
+27% +$105K 0.07% 259
2024
Q4
$374K Buy
+904
New +$397K 0.05% 306
2022
Q1
Sell
-1,654
Closed -$1.09M 439
2021
Q4
$1.09M Buy
1,654
+209
+14% +$131K 0.19% 134
2021
Q3
$899K Buy
+1,445
New +$971K 0.16% 165

Other funds holding IDXX

Moloney Securities Asset Management's IDXX Position: Q3 2025 in Review

Moloney Securities Asset Management reduced its Idexx Laboratories (IDXX) stake by 22% in Q3 2025, selling an estimated $127K and leaving 722 shares worth $461K. The position accounts for 0.05% of the portfolio, ranked #285.

Moloney Securities Asset Management first reported a position in IDXX in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.09M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Moloney Securities Asset Management held 722 shares of Idexx Laboratories worth $461K as of Q3 2025.
  • Moloney Securities Asset Management sold 209 Idexx Laboratories shares in Q3 2025, an estimated $127K.
  • Idexx Laboratories made up 0.05% of Moloney Securities Asset Management's portfolio in Q3 2025, its #285 holding.
  • Moloney Securities Asset Management first reported a position in Idexx Laboratories in Q3 2021 and has held it in 6 quarters since.
  • Moloney Securities Asset Management's Idexx Laboratories position peaked at $1.09M in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.